Bacil Pharma Limited has submitted a regulatory disclosure to BSE Limited regarding proposed appointments to its Board of Directors. The disclosure is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Board of Directors proposes to pass the following key resolutions in an upcoming Board Meeting:

1. Appointment of Mr. Aayush Shah as Non-executive Independent Director

  • Mr. Shah has overall 9 years of experience as Company Secretary and Compliance Officer
  • Professional expertise includes: Corporate Laws, Security Laws, Capital Market, Corporate Governance, FEMA Compliances, Listing Process, Liaison with Regulatory authorities, and various Compliances under Financial Services
  • Term: Appointment as an Additional Non-executive Independent Director, liable to retire by rotation
  • Subject to approval of shareholders at the next General Meeting
  • Not related to any of the existing Directors of the Company

2. Appointment of Mr. Ankitkumar Surendrakumar Agrawal as Non-executive Independent Director

  • Qualified Company Secretary and Member of the Institute of Company Secretaries of India (Membership No. ACS 53150)
  • Educational qualifications: Bachelor's degree in Business Administration from Hemchandracharya North Gujarat University and Master's in Business Administration from Sikkim Manipal University
  • Current association: Company Secretary with Prozeal Green Energy Limited since November 2023 (renewable energy sector company)
  • Previous associations: Camrola Quartz Limited and Rama Gum Industries India Limited as Company Secretary
  • Overall experience: More than 7 years as a Company Secretary
  • Professional expertise includes: Corporate Laws, Security Laws, and Liaison with Regulatory authorities
  • Term: Appointment as an Additional Non-executive Independent Director, liable to retire by rotation
  • Subject to approval of shareholders at the next General Meeting
  • Not related to any of the existing Directors of the Company

The disclosure was signed by Ms. Chaitali Kalpataru Shah, Director & CFO (DIN: 11167778) on June 29, 2026. The document also includes standard corporate information: Registered Office at G2 & G3 Samarpan Complex, Next to Mirador Hotel, Chakala, Andheri East, Mumbai - 400099, CIN: L24200MH1987PLC043427.

Financial impact not quantified in the disclosure.